Stock Markets July 13, 2026 10:55 AM

Oslo market climbs as energy and utilities names lead gains; OBX up 1.00%

Equinor and Aker BP among top advancers while Kongsberg posts the largest decline; oil prices jump on the session

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
EQNR

Norway's stock market closed higher on Monday, with the Oslo OBX index advancing 1.00% as Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities sectors provided upward momentum. Equinor led gains among OBX components while Kongsberg registered the largest drop. Oil benchmarks also climbed, while gold futures moved lower.

Oslo market climbs as energy and utilities names lead gains; OBX up 1.00%
EQNR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Oslo OBX closed up 1.00%, driven by gains in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities sectors.
  • Equinor (EQNR) led OBX advancers with a 4.92% rise; Aker BP (AKRBP) and Hafnia (HAFNI) also posted notable gains.
  • Kongsberg (KOG) recorded the largest decline among highlighted names, down 6.84%; Norwegian Air (NAS) and Nordic Semiconductor (NOD) were also lower.

Market close overview

Norwegian equities finished higher on Monday, with the Oslo OBX rising 1.00% at the close. Sector strength in Healthcare Equipment & Services, Pharma Biotech & Life Sciences and Utilities helped push the market higher by the end of trading in Oslo.

Top and bottom performers

The session's strongest performer on the OBX was Equinor ASA (OL:EQNR), which advanced 4.92% - adding 16.20 points to finish at 345.70. Aker BP ASA (OL:AKRBP) followed, climbing 3.34% or 10.30 points to close at 318.80. Hafnia Ltd (OL:HAFNI) also posted gains, ending the day 3.09% higher, up 2.15 points at 71.80.

At the other end of the index, Kongsberg Gruppen ASA (OL:KOG) suffered the steepest fall, sliding 6.84% or 20.50 points to a 279.00 close. Norwegian Air Shuttle ASA (OL:NAS) declined 2.12% or 0.29 points to end at 13.42, while Nordic Semiconductor ASA (OL:NOD) decreased 1.55% or 2.60 points to finish at 165.60.

Breadth and volume

On the Oslo Stock Exchange, advancing issues outnumbered decliners by 144 to 104, with 29 stocks unchanged at the close of trading.

Commodities and currencies

Energy benchmarks rose sharply during the session. Crude oil for August delivery increased 4.41% - up 3.15 to $74.56 a barrel. Brent futures for September delivery climbed 4.34%, adding 3.30 to reach $79.31 a barrel. Precious metals moved in the opposite direction as the August Gold Futures contract fell 2.37% or 97.30 to trade at $4,016.40 a troy ounce.

Currency moves included EUR/NOK rising 0.10% to 11.15 and USD/NOK increasing 0.17% to 9.78. The US Dollar Index Futures ticked up 0.20% to 100.96.


Implications

The session featured notable strength among energy-related listings and select utilities, while industrial and semiconductor names showed weakness. Market breadth favored gainers, and commodity price action displayed a clear divergence between oil and gold on the day.

Data points cited in this article reflect session-close prices and percentage moves reported for the trading day.

Risks

  • Commodity volatility - sharp moves in crude and Brent prices could affect energy and related sectors that contributed to the market rise.
  • Sector-specific weakness - declines in industrials and semiconductors, exemplified by Kongsberg and Nordic Semiconductor, may signal concentrated downside risk for those sectors.
  • Currency fluctuations - changes in EUR/NOK and USD/NOK may influence earnings and cost structures for exporters and importers operating in Norway.

More from Stock Markets

Vossloh Lowers 2026 Revenue and Profit Guidance Citing Demand Timing and Cost Pressures Jul 13, 2026 Pentagon Commits $25 Million to ReElement Technologies to Bolster Domestic Rare Earth Production Jul 13, 2026 BofA Picks Micron as Top AI Memory Beneficiary, Sees Valuation Upside Jul 13, 2026 Sunrun tests program to pay homeowners for routing rooftop solar to distributed computing Jul 13, 2026 FDA Sets September Public Hearing on Psychedelic Therapies as Final Guidance Emphasizes Interpretable Data Jul 13, 2026